ArticleCancers2022

Targeting IGF2BP2 Promotes Differentiation of Radioiodine Refractory Papillary Thyroid Cancer via Destabilizing RUNX2 mRNA.

Ri Sa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.